Linguamatics Ltd Extends License to Its Agile Text Mining Platform for AstraZeneca PLC

CAMBRIDGE, England--(BUSINESS WIRE)--Linguamatics, a leader in enterprise text mining for the life science and other markets, today announced that AstraZeneca, a customer of Linguamatics since 2003, has extended its license to the I2E semantic knowledge-discovery platform with a further multi-year deal. I2E provides flexible and scalable enterprise text mining within AstraZeneca’s knowledge engineering strategy, and supports decision making at many points in the drug discovery process, including target selection, biomarker discovery and safety/toxicology. Financial details of the agreement were not disclosed.

Back to news